REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
etesevimab (JS016) - Chinese Academy of Sciences, Shanghai Junshi Biosci, Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/38721976
 
Junzhao Liu; Kaili Dai; Linna Luo; Mingyang Yang
 
May 9, 2024
 
Next